| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |